Histology and Cytology Market Introduction and Overview
According to SPER Market Research, the Global Histology and Cytology Market is estimated to reach USD 24.89 billion by 2033 with a CAGR of 12.11%.
The report includes an in-depth analysis of the Global Histology and Cytology Market, including market size and trends, product mix, applications, and supplier analysis. The crucial fields of study in medicine that are used to diagnose disorders of the organs, tissues, and body fluids are histology and cytology. Since histology and cytology are essential components of pathology, their use is predicted to grow significantly during the next ten years as a result of technological developments, research and development efforts, and other factors. Over the next few years, developments in digital pathology are expected to open up new avenues for innovations, data collection methods, and diagnostic treatment; as a result, the worldwide histology and cytology market is expected to have a prosperous future.
- January 2024; BD and TechCyte worked together to create a computerized cervical cytology system. This technology improves productivity and accessibility in cytology labs by enabling sample scanning, digital slide image conversion, and remote review on a computer display.
- October 2023; The miLab Cartridge CER, a specialized tool for automated cervical cell staining and evaluation, was introduced by Noul Co., Ltd. Whether cervico-vaginal smear samples are collected using liquid-based cytology (LBC) or manually produced, this cervical cell analysis equipment is designed to accommodate them.
Market Opportunities and Challenges
The medical sector is growing faster than ever because of the increased prevalence of chronic diseases such lymphoma cancer, nephrological cancer, leukemia, myeloma, etc. Multiple emerging technologies are used in reliable and efficient testing procedures. The goal of these diagnostic techniques is to find symptoms early on so that treatment may begin right away. By allowing the expert to view the sample slide remotely, digital imaging improves the quality and efficacy of histology and cytology services. Glass slides or transport pathologists can save time by not having to ship slides because of the enhanced accessibility. It is therefore likely that the market for histology and pathology will be driven by technology advancements in disease diagnoses. The expansion of the global histology and cytology market is anticipated to be hampered by the strict government rules, norms, and intricate procedures related to these fields. For example, fixing, dehydrating, embedding, sectioning, and other processes are among the steps involved in the preparation of histological specimen slides, and they can all be challenging and time-consuming. Moreover, one of the main problems that will probably stop the company from expanding is contamination from laboratory equipment. A surgical pathology diagnosis that is falsely positive is the consequence of contaminated cytology and histology materials. In particular, contaminants that come from fungus and mold may be harmful to the lab.
Market Competitive Landscape
Leading companies in the worldwide histology and cytology markets are attempting to introduce automated digital imaging technologies that can improve the capacity for result interpretation. Due to recent improvements in the healthcare infrastructure, businesses are concentrating more and more on developing economies, where there is enormous unrealized income potential. Key corporate restructuring market players are Abbott Laboratories, Danaher, Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Trivitron Healthcare, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Southwest Precision Instruments, Allergan, Merck KGaA, Promega Corporation
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product Type, By Application, By End User
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Abbott Laboratories, Danaher, Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Trivitron Healthcare, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Southwest Precision Instruments, Allergan, Merck KGaA, Promega Corporation
|
COVID-19 Impact on Global Histology and Cytology Market
Global public health is at risk due to the advent of the coronavirus disease (COVID-19). The COVID-19 pandemic outbreak is anticipated to have a moderate effect on the global market for histology and cytology in 2020. Governments have designated healthcare services as essential; therefore the industry is generally expected to continue operating during the epidemic. Additionally, as the COVID-19 pandemic worsens, scientists and medical professionals are concentrating more on comprehending the pathological alterations in different organs in COVID-19-affected patients. While the respiratory and immunological systems are the main targets of COVID-19, other systems such as the cardiovascular, integumentary, reproductive, neurological, and urinary and gastrointestinal tracts may also be compromised.
Key Target Audience:
- Pathologists
- Cytotechnologists
- Oncologists
- Haematologists
- Dermatopathologists
- Nephropathologists
- Neuropathologists
- Urologists
- Gastroenterologists
- Research Institutions
Our in-depth analysis of the Histology and Cytology Market includes the following segments:
|
By Product Type: |
Kits and Reagents
Enzymes
Stains and Dyes
Others
|
|
By Application: |
Molecular Diagnostic Study
Cell Signaling
Clinical Diagnosis
Epigenetics and Sequencing Study
Other Applications
|
|
By End User: |
Hospitals
Diagnostic Centers
Biotechnology and Pharmaceutical Industry
Academic Research Institutes
Other End Users
|
Key Topics Covered in the Report:
- Global Histology and Cytology Market Size (FY’2024-FY’2033)
- Overview of Global Histology and Cytology Market
- Segmentation of Global Histology and Cytology Market By Product Type (Kits and Reagents, Enzymes, Stains and Dyes, Others)
- Segmentation of Global Histology and Cytology Market By Application (Molecular Diagnostic Study, Cell Signaling, Clinical Diagnosis , Epigenetics and Sequencing Study, Other Applications)
- Segmentation of Global Histology and Cytology Market By End User (Hospitals, Diagnostic Centers, Biotechnology and Pharmaceutical Industry , Academic Research Institutes , Other End Users)
- Expansion Analysis of Global Histology and Cytology Market
- Problems and Obstacles in Global Histology and Cytology Market
- Competitive Landscape in the Global Histology and Cytology Market
- Impact of COVID-19 and Demonetization on Global Histology and Cytology Market
- Details on Current Investment in Global Histology and Cytology Market
- Competitive Analysis of Global Histology and Cytology Market
- Prominent Players in the Global Histology and Cytology Market
- SWOT Analysis of Global Histology and Cytology Market
- Global Histology and Cytology Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Histology and Cytology Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Histology and Cytology Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Histology and Cytology Market
7. Global Histology and Cytology Market, By Product Type (USD Million) 2020-2033
7.1. Global Histology and Cytology Market Size, Share and Forecast, By Product Type, 2020-2026
7.2. Global Histology and Cytology Market Size, Share and Forecast, By Product Type, 2027-2033
7.3. Kits and Reagents
7.4. Enzymes
7.5. Stains and Dyes
7.6. Others
8. Global Histology and Cytology Market, By Application (USD Million) 2020-2033
8.1. Global Histology and Cytology Market Size, Share and Forecast, By Application, 2020-2026
8.2. Global Histology and Cytology Market Size, Share and Forecast, By Application, 2027-2033
8.3. Molecular Diagnostic Study
8.4. Cell Signaling
8.5. Clinical Diagnosis
8.6. Epigenetics and Sequencing Study
8.7. Other Applications
9. Global Histology and Cytology Market, By End User (USD Million) 2020-2033
9.1. Global Histology and Cytology Market Size, Share and Forecast, By End User, 2020-2026
9.2. Global Histology and Cytology Market Size, Share and Forecast, By End User, 2027-2033
9.3. Hospitals
9.4. Diagnostic Centers
9.5. Biotechnology and Pharmaceutical Industry
9.6. Academic Research Institutes
9.7. Other End Users
10. Global Histology and Cytology Market Forecast, 2020-2033 (USD Million)
10.1. Global Histology and Cytology Market Size and Market Share
11. Global Histology and Cytology Market, By Region, 2020-2033 (USD Million)
11.1. Global Histology and Cytology Market Size and Market Share By Region (2020-2026)
11.2. Global Histology and Cytology Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle East & Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Danaher
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Becton Dickinson and Company
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. F. Hoffmann-La Roche Ltd
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Sysmex Corporation
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Trivitron Healthcare
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Agilent Technologies Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Thermo Fisher Scientific Inc.
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Southwest Precision Instruments
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Merck KGaA
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
